sar408701,pembrolizumab,ramucirumab,docetaxel,tusamitamab ravtansine
aventis,sanofi,merck,2seventy bio,eli lilly
['ceacam5', 'pembro', 'ramucirumab', 'solid tumor', 'biomarker', 'docetaxel', 'tusamitamab', 'lung', 'nsclc', 'ide cel', 'sclc', 'sar408701', 'msd']
nice session biomarkers/new treatments and caecam targeting in lung cancer natasha.leighl #esmoimmuno22 
Thoracic Oncologist - Head of Thoracic Group, Department of Medical Oncology - Institut Gustave Roussy (IGR) - Villejuif - France ???? and CICT member